FMS | Pain | Psychopharmacology

Composed of leading rheumatologists, the role of the FMS Advisory Board includes providing expertise related to FMS pathophysiology and therapeutic approaches to the disorder. The advisory board also works with us to (i) select and evaluate the potential effectiveness of drug candidates, (ii) design clinical trials, (iii) recruit patients for studies from their practices, and (iv) collaborate with us on innovative scientific efforts directed at FMS.

Daniel J. Clauw, M.D. - Chairman
Director, Center for the Advancement of Clinical Research
Professor of Medicine
University of Michigan

Dr. Daniel Clauw is Professor of Medicine and Director of the Chronic Pain and Fatigue Research Center at the University of Michigan. He also directs the Center for the Advancement of Clinical Research, an organization that provides support and infrastructure for all clinical research at the University of Michigan. His expertise includes fibromyalgia, chronic fatigue syndrome and gulf war syndrome. In addition to his work at the University of Michigan, Dr. Clauw serves as Consultant to the Department of Veterans' Affairs Studies: "National Survey of Persian Gulf Veterans and their Families" and "Treatment of Fibromyalgia and Chronic Fatigue Syndrome in Persian Gulf Veterans". His recent research has focused on fibromyalgia and related illnesses, both on the mechanisms involved and the most effective treatments.

Other FMS Advisory Board members include:

Robert Bennett, M.D., FRCP
Professor of Medicine
Oregon Health & Science University

Don L. Goldenberg, M.D., Ph.D.
Chief Rheumatology, Newton-Wellesley Hospital
Professor of Medicine, Tufts University School of Medicine

Philip Mease, M.D.
Seattle Rheumatology Associates
Swedish Medical Center, Division of Clinical Research
Clinical Professor, University of Washington